Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.

The latest MedNous journal. Subscribe to download.

Novo acquires Xellia Pharmaceuticals for $700 million

Country: Norway

Novo A/S, the financing entity that is at the apex of Denmark’s pharmaceutical industry, has acquired all the share capital of Xellia Pharmaceuticals AS of Norway for about $700 million. One of the sellers was Britain’s 3i Group Plc.

Read more

SuppreMol gets additional series D financing

Country: Germany

SuppreMol GmbH, which specialises in autoimmune diseases, has raised €9.5 million as the second part of a €16 million series D financing for the Phase 2 development of its lead autoimmune drug candidate.

Read more

Wellcome Trust funds cancer prognosis project

Country: United Kingdom

Read more

Activists applaud stem cell breakthrough

Country: United States

Read more

Galápagos and AbbVie extend JAK1 alliance

Country: Belgium

Read more

Sanofi reports on JAK2 inhibitor in MF

Country: France

Read more

Algeta cancer treatment approved by FDA

Country: United States

Read more

Evotec confirms financial guidance

Country: Germany

Read more

Cardio3 BioSciences raises €19 million

Country: Belgium

Read more

Hormone said to control pancreatic beta-cell proliferation

Country: United States

Read more

Genetic risk for osteoporosis reported

Country: Iceland

Read more

Looking for more?

Visit our news section for more articles.

News
Our full Mednous news archive
Appointments
Latest industry appointments
Events
A list of upcoming industry events

About Mednous

MedNous is a print publication and a website for everyone involved in medical research in Europe.

Read more

Free Article

The changing model for rare disease R&D

Orphan drug strategyFinnMay2013.pdf

Highlights of the May 2013 MedNous issue

The May 2013 MedNous features:

Latest Mednous cover
  • Financial Strategy
    How Sweden’s HealthCap
    expanded globally
  • Business Strategy
    The changing model for
    rare disease R&D
  • Case Study
    Finding a drug for
    Duchenne muscular
    dystrophy
  • Building the life science sector in Catalonia
    By Montserrat Vendrell
  • Commentary:
    China eclipses Europe for biobusiness
    By Gareth Williams

The latest MedNous journal. Subscribe to download.